TrialCancer control : journal of the Moffitt Cancer Center

Raltitrexed Chemotherapy Regimen Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer: A Prospective Multicenter Phase II Trial.

Sheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.